CLICK4HP Archives

Health Promotion on the Internet

CLICK4HP@YORKU.CA

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Mime-Version:
1.0
Sender:
Health Promotion on the Internet <[log in to unmask]>
Subject:
From:
Madeline Boscoe <[log in to unmask]>
Date:
Wed, 14 Oct 2009 08:45:59 -0500
Content-Transfer-Encoding:
quoted-printable
Content-Type:
text/plain; charset="iso-8859-1"; format=flowed
Reply-To:
Health Promotion on the Internet <[log in to unmask]>
Parts/Attachments:
text/plain (69 lines)
Hello there:
I thought  perhaps members of this list might be 
interested in this. Barbara  is a member of the 
Women and Health Protection Working Group , 
http://www.whp-apsf.cawhich has been doing work on pharmaceuticals and women.
- with regards, Madeline


Anti-depressants in pregnancy: Is there evidence of benefit?

WEBINAR - Thursday Oct. 29, 2009 from 12:30 - 1:30 p.m. EDT

Canadian Women's Health Network presents Dr. 
Barbara Mintzes, Assistant Professor, UBC 
Department of Pharmacology & Therapeutics, UBC 
Centre for Health Services & Policy Research, and 
Steering Committee member, Women and Health Protection


Antidepressants are increasingly being used to 
treat depression in pregnancy in Canada despite 
their lack of approval for this use by Health 
Canada or the US FDA. Recent scientific and 
public attention has focused on an increased risk 
for infants, and this has led to conflicting 
advice about the use of SSRI/SNRI antidepressants 
(such as Prozac, Paxil, Effexor, or other related 
drugs) during pregnancy. Some suggest avoiding 
all exposures, while others recommend use in 
order to avoid harm to mothers and infants from untreated depression.

Mintzes will present what she and colleagues 
found in a systematic evaluation of all available 
studies comparing women with depression who did 
or did not take antidepressants during pregnancy. 
Their goal was to find an answer to the 
controversial and urgent clinical question: do 
pregnant women benefit from taking antidepressants?

This research and this webinar are funded by 
Health Canada’s Women’s Health Contribution Program.

_______________________________________

The webinar is free of charge and open to the public.
You will need a computer with a high speed 
internet connection and speakers (or a headset).

Please email <mailto:[log in to unmask]>[log in to unmask] for registration information.

If you would like to suggest a question for Dr. 
Mintzes, please email it along with your registration request.

-
Jane Shulman
Director of Knowledge Exchange / Courtière de connaissances
Canadian Women's Health Network / Le Réseau canadien pour la santé des femmes
Tel/Tél: (204) 942-5500 x15
Fax./Téléc.: (204) 989-2355
203-419 Graham Ave
Winnipeg, MB R3C 0M3

Support a national voice for women's health!
Appuyez une voix nationale pour la santé des femmes !
<http://www.cwhn.ca/>www.cwhn.ca


To manage subscriptions/passwords, or view archives, go to http://listserv.yorku.ca/archives/click4hp.html . [log in to unmask] is run in collaboration with Health Nexus: http://www.healthnexus.ca/index_eng.php

ATOM RSS1 RSS2